Found: 9
Select item for more details and to access through your institution.
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1010835
- By:
- Publication type:
- Article
Omicron BA.1, BA.2 and COVID-19 Booster Vaccination.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1480, doi. 10.1093/infdis/jiac158
- By:
- Publication type:
- Article
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 8, p. 1372, doi. 10.1093/infdis/jiac092
- By:
- Publication type:
- Article
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 180, doi. 10.3390/vaccines12020180
- By:
- Publication type:
- Article
COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 391, doi. 10.3390/vaccines10030391
- By:
- Publication type:
- Article
Molecular characterization of serine protease inhibitor isoform 3, SmSPI, from Schistosoma mansoni.
- Published in:
- Parasitology Research, 2016, v. 115, n. 8, p. 2981, doi. 10.1007/s00436-016-5053-y
- By:
- Publication type:
- Article
Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 8, p. 1781, doi. 10.3390/diagnostics12081781
- By:
- Publication type:
- Article
Comparison of the reactogenicity and immunogenicity between two‐dose mRNA COVID‐19 vaccine and inactivated COVID‐19 vaccine followed by an mRNA vaccine in children aged 5−11 years.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 5, p. 1, doi. 10.1002/jmv.28758
- By:
- Publication type:
- Article
Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 12, p. 5713, doi. 10.1002/jmv.28044
- By:
- Publication type:
- Article